Medtronic Cardiac Rhythm and Heart Failure

Clinical trials sponsored by Medtronic Cardiac Rhythm and Heart Failure, explained in plain language.

Now part of Medtronic plc MDT NYSE

A division of Medtronic focused on cardiac rhythm management and heart failure devices.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Can a new device make pacemaker placement more precise? Results expected Jul 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 5 Not yet recruiting 1 Not yet finished but already full! 5 Completed 7 Terminated 2

Could two pacing leads be better than one for failing hearts?

Disease control Not yet recruiting

This study compares two pacing methods in 80 people with heart failure and a specific heart block. One method uses a lead placed in the left bundle branch area; the other adds a second lead in the left ventricle. Each participant will try both methods for six months to see which …

Sponsor: Medtronic Cardiac Rhythm and Heart Failure • Aim: Disease control

Last updated Aug 20, 2026 00:00 UTC

Medtronic Cardiac Rhythm and Heart Failure

Upcoming readouts

Could two pacing leads be better than one for failing hearts?